subscribeSubscribe
AZ hit with fine in Korea over plot to stall generic of lucrative cancer med

AZ hit with fine in Korea over plot to stall generic of lucrative cancer med
Fraiser Kansteiner FIERCEPHARMA
14 Oct 2022
Share Share
Myovant`s oral prostate cancer drug matches incumbent in phase 3

Myovant`s oral prostate cancer drug matches incumbent in phase 3
N. P Taylor FIERCE BIOTECH
20 Nov 2019
Share Share
Myovant`s oral prostate cancer drug matches incumbent in phase 3

Myovant`s oral prostate cancer drug matches incumbent in phase 3
N. P Taylor FIERCE BIOTECH
20 Oct 2019
Share Share
Myovant`s oral prostate cancer drug matches incumbent in phase 3

Myovant`s oral prostate cancer drug matches incumbent in phase 3
N. P Taylor FIERCE BIOTECH
20 Oct 2019
Share Share
AstraZeneca cuts 94 jobs from UK campus

AstraZeneca cuts 94 jobs from UK campus
Ben Hargreaves IN-PHARMATECHNOLOGIST
27 Mar 2019
Share Share
AstraZeneca sells 3 drugs for $350M upfront

AstraZeneca sells 3 drugs for $350M upfront
Suzanne Elvidge BIOPHARMADIVE
11 Mar 2019
Share Share
Astra`s Soriot Says Slow Pace of Brexit Talks an Area of Concern

Astra`s Soriot Says Slow Pace of Brexit Talks an Area of Concern
John Lauerman BLOOMBERG
06 Sep 2017
Share Share
AstraZeneca to invest £150m in new facility

AstraZeneca to invest £150m in new facility
Marc Hauschild THE MANUFACTURE
05 Sep 2017
Share Share
AZ confirms Macclesfield plan but says “wait to see” Brexit strategy unchanged

AZ confirms Macclesfield plan but says “wait to see” Brexit strategy unchanged
G. MacDonald IN PHARMATECHNOLOGIST
29 Aug 2017
Share Share
AstraZeneca sells off cancer drug to TerSera for $250 million

AstraZeneca sells off cancer drug to TerSera for $250 million
Ben Hargreaves PHARMAFILE
21 Feb 2017
Share Share